超灵敏超声微血管成像用于乳腺良恶性肿瘤的鉴别
研究纳入44例患者共51个乳腺肿块(28个恶性、23个良性),以病理为金标准,评估超灵敏超声微血管成像(UMI)对乳腺肿瘤良恶性鉴别的价值。UMI较常规多普勒能更显著显示小血管,其微血管形态与肿瘤良恶性分类相关;常规超声联合UMI后,BI-RADS分类正确率较单用常规超声提高16%。
要点
- UMI较常规多普勒显著改善小血管显示,微血管形态与乳腺肿瘤良恶性分类相关。
- 常规超声联合UMI后,BI-RADS分类正确率较单用常规超声提高16%。
- UMI有望减少不必要的良性活检并避免漏诊恶性活检。
核心结论
- UMI较常规多普勒显著改善小血管显示,其微血管形态与乳腺肿瘤良恶性分类相关;常规超声联合UMI后BI-RADS分类正确率较单用常规超声提高16%,提示UMI有望减少不必要的良性活检并避免漏诊恶性活检。
研究设计与样本
- 研究纳入44例患者共51个乳腺肿块,以肿瘤病理为金标准(28个恶性、23个良性),评估超灵敏超声微血管成像(UMI)的性能。
关键影像表现/征象
- UMI较常规多普勒显著改善小血管显示。
- UMI上观察到的微血管形态与肿瘤良恶性分类相关。
诊断标准与关键数值
- 以病理为金标准,共28个恶性、23个良性乳腺肿块。
- BI-RADS≥4a判为阳性、BI-RADS≤3判为阴性,常规超声联合UMI后BI-RADS分类正确率较单用常规超声提高16%。
临床应用与阅片要点
- 常规超声联合UMI可提高BI-RADS分类正确率,较单用常规超声提高16%。
- UMI显示的微血管形态与肿瘤良恶性分类相关,提示其有减少不必要良性活检和避免漏诊恶性活检的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Tumor angiogenesis plays an important role during breast tumor growth. However, conventional Doppler has limited sensitivity to detect small blood vessels, resulting in a large overlap of Doppler features between benign and malignant tumors. An ultrasensitive ultrasound microvessel imaging (UMI) technique was recently developed. To evaluate the performance of UMI, we studied 44 patients with 51 breast masses. Tumor pathology served as the gold standard: 28 malignancies and 23 benignities. UMI provided a significant improvement in depicting smaller vessels compared with conventional Doppler. The microvessel morphologies observed on UMI were associated with tumor benign/malignant classification. The diagnostic accuracy of correct Breast Imaging Reporting and Data System (BI-RADS) classification rate (BI-RADS ≥4a: test positive; BI-RADS ≤3: test negative) as a fraction of total mass population was improved by 16% after combining conventional ultrasound with UMI compared with using conventional ultrasound alone. This improvement indicates the potential of UMI in reducing unnecessary benign biopsies and avoiding missed malignant biopsies.
引用
- Gong P, Song P, Huang C, et al. Ultrasensitive Ultrasound Microvessel Imaging for Characterizing Benign and Malignant Breast Tumors. Ultrasound Med Biol. 2019. PMID: 31530420. doi:10.1016/j.ultrasmedbio.2019.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。